COVID-19-Associated Neuropathy A Case Report and Literature Review Author
International Internal Medicine Journal · 2023
DOI: 10.33140/iimj.01.03.002 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Internal Medicine Journal, 2023.
Abstract (Originalsprache)
Objective
The goal of this succinct case report and literature analysis is to shed light on the symptoms, diagnosis, course, and outcomes of COVID-19-associated neuropathy.
Method
An instance of chronic peripheral neuropathy that developed after a COVID-19 infection is presented. Neurologists, infectious disease experts, and rehabilitation specialists are involved in the diagnostic workup and multidisciplinary management detailed here. An in-depth analysis of the literature on COVID-19-related neuropathy was performed.
Results
Following COVID-19, the patient continued to experience symptoms of peripheral neuropathy. Diagnostic testing confirmed neuropathy. Medication, rehabilitation, and supportive care were all part of the treatment. The review of the literature added knowledge about pathophysiology, diagnostics, and therapeutic strategies.
Conclusion
Neuropathy brought on by COVID-19 is a significant clinical problem. This brief report emphasizes the ongoing peripheral neuropathy caused by COVID-19. The thorough management strategy and literature review improve comprehension of the diagnosis and course of action. Early detection is crucial for the best results.
Zitieren
APA
(2023). COVID-19-Associated Neuropathy A Case Report and Literature Review Author. International Internal Medicine Journal. https://doi.org/10.33140/iimj.01.03.002
Vancouver
COVID-19-Associated Neuropathy A Case Report and Literature Review Author. International Internal Medicine Journal. 2023. doi:10.33140/iimj.01.03.002
BibTeX
@article{euvimed2023,
title = {COVID-19-Associated Neuropathy A Case Report and Literature Review Author},
journal = {International Internal Medicine Journal},
year = {2023},
doi = {10.33140/iimj.01.03.002}
}
EUVIMED